FDA panel recommends approving Pfizer’s COVID-19 vaccine emergency use authorization

There are two vaccine which is recommended by an independent panel of experts and approved Emergency by Food and Drug Administration (FDA) named the Pfizer and BioNTech for COVID-19.

According to TechCrunch, it is such a huge news and first step toward news beginning to be administered to people in special circumstances, especially for the health worker dealing with healthcare facilities stressed to the breaking point due to the ongoing and rising pandemic crisis in the U.S, constantly graining a record cases day by day and the death counts also increased among afflicted patients.

The Pfizer/BionNTech vaccine is an mRNA vaccine, that means it provides a set of instructions to a person’s cells to prompt them to begin creating antibodies that are effective against the SARS-CoV-2 virus that leads to COVID-19.

Until now, the vaccine has shown a great result and approximately 95% effective according to Pfizer’s own final trial data. Based on the strength of those Phase 3 results, Pfizer applied for an EUA from the FDA toward the end of November.

Already, Pfizer’s vaccine has been approved in many countries. One country is Canada, where the national health regulator cleared it earlier this week. The FDA’s EUA process involves reviewing key information about efficacy and safety, and the agency says that it has “reviewed thousands of pages of technical information” about the Pfizer/BioNTech vaccine, including materials related to its development and manufacturing, as well as the results of its clinical trials to date.